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P53Abstract Maintenance of tissue-specific stem cells is vital for organ homeostasis and organismal
longevity. Hematopoietic stem cells (HSCs) are the most primitive cell type in the hematopoietic
system. They divide asymmetrically and give rise to daughter cells with HSC identity (self-
renewal) and progenitor progenies (differentiation), which further proliferate and differentiate into
full hematopoietic lineages. Mammalian ageing process is accompanied with abnormalities in the
HSC self-renewal and differentiation. Transcriptional changes and epigenetic modulations have
been implicated as the key regulators in HSC ageing process. The DNA damage response (DDR)
in the cells involves an orchestrated signaling pathway, consisting of cell cycle regulation, cell death
and senescence, transcriptional regulation, as well as chromatin remodeling. Recent studies employ-
ing DNA repair-deficient mouse models indicate that DDR could intrinsically and extrinsically reg-
ulate HSC maintenance and play important roles in tissue homeostasis of the hematopoietic system.
In this review, we summarize the current understanding of how the DDR determines the HSC fates
and finally contributes to organismal ageing.Introduction
In adult animals, tissue homeostasis is maintained by a hierar-
chy of different types of cells, ranging from tissue-specific stemcells, progenitors, to somatic cells with different functions [1].
Stem cells are the most primitive cell population in a specific
tissue, which on the one hand self-renew to sustain the stem
cell pool, and on the other hand differentiate to generate their
somatic progenies [1,2]. Dysregulation of self-renewal and
differentiation of tissue-specific stem cells compromises the
stem cell function, resulting in loss of tissue maintenance and
organismal ageing [1,3,4].
Among all types of tissue-specific stem cells, hematopoietic
stem cell (HSC) is considered as the prototype to study the
functions of genes of interest in adult stem cell self-renewal
and maintenance, as well as their roles in physiological ageingnces and
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niches (bone marrow stromal cells) and are exposed to system-
atic environments consisting of cytokine, chemokine (Figure 1),
and other factors [7]. The advantages of using the HSCs as the
model to study stem cell ageing are mainly due to: (1) well-
defined HSCs and their progenies with combinations of cell sur-
face markers; (2) a panel of sophisticated in vitro assays to verify
the HSC functions; and (3) the adoptive HSC transplantation
assay as a gold standard to test stem cell functions [5]. Using
naturally-aged wild type mice and genetically-modified prema-
ture ageing mouse models [8–13], intrinsic and extrinsic factors
contributing to the HSC ageing start to be unraveled [4,14–16].
Among them, cell cycle regulators, transcriptional factors, epige-
netic modulators, and metabolic pathways have been implicated
as important regulators for HSC self-renewal and maintenance
during ageing process [10,12,17–23].
DNA lesions in cells originate from endogenous cellular
activities, such as DNA replication and mitochondrial respira-
tion, as well as exogenous stimuli, such as therapeutic drugs
against cancers and medical exposure to irradiation, posing
direct threats to the integrity of the cellular genetic information
[24–26]. If these DNA lesions could not be handled well, they
will compromise cellular viability and drive the tumor forma-
tion [27,28]. When it comes to the HSCs, improper repair of
DNA lesions could negatively regulate the HSC maintenance
and lead to HSC ageing [4,8,26]. Here, we concisely discuss
the signatures defining ‘‘aged HSCs” and the role of genomic
stability in HSC ageing.Characteristics of HSCs in ageing hematopoietic
system
Compared to the young individuals, the frequency (percentage
of HSCs within bone marrows) and absolute numbers of
HSCs, which are phenotypically designated with defined sur-
face markers, increase in naturally-aged individuals of mice
and humans (Figure 1) [8,29,30]. However, HSCs in aged miceFigure 1 Characteristics of aged HSCs
HSCs from aged mice show distinct phenotypic features and molecular
a combinatorial effect from intrinsic determinants and extrinsic signal
hematopoietic stem cell; SASP, senescence-associated secretory phen
HSC; Ly-Bi-HSC, lymphoid-biased HSC.are defective in the self-renewal capacity [31]. The adoptive
bone marrow transplantation assay is the ‘‘gold standard” to
investigate the HSC functionality. Upon transplantation,
HSCs are forced to enter the cell cycle and differentiate into
different hematopoietic lineages [32]. The sequential transplan-
tation with the HSCs from the primary transplantation could
be further employed to test the robustness of HSCs in
self-renewal. During the serial transplantation, HSCs get
exhausted and step into an ‘‘aged” status [12,33]. Using this
serial adoptive transplantation assay, aged HSCs (HSCs from
aged mice) showed limited repopulation ability to replenish the
hematopoietic system in bone marrow-ablated congenic mice
[12,29]. The HSC transplantation assay indicates that the aged
HSCs, in addition to a homing defect (a failure of transplanted
donor HSCs trafficking to and engrafting in recipient bone
marrows), only represent around 25% efficiency of HSCs from
young animals [29].
Furthermore, aged HSCs have differentiation defects as
well (Figure 1). Peripheral blood (PB) from aged mice con-
tains a relative higher proportion of myeloid cells, such as
Mac1 + and Gr1+ hematopoietic cells, as compared to
the PB from young animals [29,34,35], which could be
attributed to the higher proportion of myeloid progenitors
generated in the bone marrow of aged mice [36]. The biased
myeloid hematopoiesis in the aged mice is detrimental to
hematopoietic system functions since the dysregulated out-
put of lymphoid and myeloid cells would compromise the
immunological response upon injury or infection in the aged
animals and further promote ageing. This skewed differenti-
ation is cell-autonomous, since transplanting aged HSCs to
young mice could recapitulate the phenotypes of ‘‘ageing”
hematopoietic compartments in these recipient mice [34,36].
The increased ratio of myeloid vs. lymphoid hematopoietic
cells in ageing is further attributed to altered heterogeneity
in HSC compartments during the ageing process [37,38].
Based on their differentiation capabilities, HSCs are further
divided into lymphoid-biased HSCs (Ly-Bi HSCs), myeloid-
biased HSCs (My-Bi HSCs), and balanced HSCs [17,37].profiles as compared to HSCs in young animals. The HSC ageing is
s, such as niche cells and systematic environmental factors. HSC,
otype; My, myeloid; Ly, lymphoid; My-Bi-HSC, myeloid-biased
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toward My-Bi HSCs during ageing.
In addition to the aforementioned phenotypically-defined
characteristics, aged HSCs are distinct from young HSCs due
to their unique transcriptomic and epigenomic features
[39–41]. Aged HSCs are implicated with marked increase in
the expression of genes involved in stress responses, inflamma-
tion, and protein aggregation, while the expression of factors
responsible for DDR and chromatin remodeling is reduced
(Figure 1) [40]. Accordingly, aged HSCs accumulate DNA
lesions [8], are defective in protein homeostasis, and exhibit
abnormal epigenetic landscapes on DNAs and histones
[9,39,40]. DNA methylation is enriched specifically on the pro-
moter regions of lymphoid and erythroid lineage genes [9]. On
the contrary, promoters of genes responsible for the myeloid
lineages exhibit reduced DNA methylation. This finding corre-
lates with the skewed hematopoietic lineage output in aged
mice [8,36,42]. Furthermore, hypo-methylated cysteines and
active chromatin markers, such as H3K9me3 and
H3K27me3, are enriched in the promoter regions of genes in
the Gene Ontology categories of cell adhesion, proliferation,
and ribosome, which are expressed higher in the aged HSCs
than in the young ones [39]. Such transcriptional and epigenetic
alterations could partially explain the phenotypic characteris-
tics of aged HSCs, such as an increased mobilization, reduced
homing ability, and loss of quiescence [29,39].
DNA damage accumulation in HSC ageing
In somatic cells, loss of genomic integrity compromises the cel-
lular viability and threatens the genetic information passage
from parent cells to daughter cells [43]. Accumulation of geno-
mic instability has been implicated in the hematopoietic malig-
nancy, which could be derived from transformed HSCs [26,28].
DNA lesions initiate DDR and induce chromatin remodeling,
epigenetic modification, as well as transcriptional regulation,
which consequently activate a series of cellular responses
including DNA repair, cell cycle checkpoint, cellular senes-
cence, and cell death [24–26,43]. All of these pan-genome, epi-
genome, and transcriptome modifications definitely generate
systematic outcome to shape the dynamics of the HSCs in
the context of self-renewal and differentiation [44,45].
The first direct link of DNA damage and HSC ageing
comes from the analysis of double strand breakage (DSB) mar-
ker c-H2AX in murine HSCs [8]. Rossi and colleagues investi-
gated the DNA damages inside aged murine HSCs and noticed
that aged HSCs accumulate high levels of DNA DSBs [8].
However, a recent study suggested that those c-H2AX marked
‘‘DSB foci” may not be real DNA breaks. The ‘‘DSB foci” are
nucleolar-associated and represent the residual replication
stress during the HSC cycling [46]. The ‘‘c-H2AX foci” severs
as the chromatin repressive marker for the silencing of rDNA
transcription, which compromises the ribosome biogenesis in
aged HSCs [46]. Interestingly, Beerman et al. used the alkaline
comet assay, which is extensively used in the field of DNA
repair as the indicator for the DSBs and single strand breaks
(SSBs) [47,48], to compare the DNA damages in young and
aged quiescent HSCs. As a result, they noticed that aged HSCs
have a high degree of DNA breaks, as indicated with increased
‘‘Olive tail moment” [9,48]. Similar to the murine HSCs,
c-H2AX antibody staining on human CD34+ HSCs andhematopoietic progenitors reveals an significant accumulation
of DSBs during normal ageing process [49]. These data indi-
cate that murine and human HSCs experience similar biologi-
cal processes, namely genomic instability, during physiological
ageing.
How are these DNA breaks generated in HSCs under phys-
iological conditions during the ageing process? Reactive oxy-
gen species (ROS) generated from metabolic pathways in
quiescent HSCs and replication errors during HSC prolifera-
tion could be the threats to genome integrity in HSCs
[33,50,51]. Using different mouse models that harbor deficien-
cies in DNA repair pathways, it is found that loss of DNA
repair factors results in accumulation of DNA damages in
HSCs and severely- compromised capabilities of HSCs for
self-renewal and differentiation under physiological conditions
[8,11,52–54]. For examples, knockout mice with defects in
DNA DSB repair and quenching the ROS (such as Atm-/-
mice) or in resolving the replication fork stalls (knockout of
Fancd2 pathway members) are ageing-prone and show defec-
tive hematopoiesis [51,55,56]. These findings strongly indicate
that the proper repair of DNA damage is important for the
maintenance of HSCs and protects against functional decline
of HSCs during ageing [4,8,26,45].
DNA repair pathway choices in HSCs
In order to fix DNA breaks, cells are equipped with different
repair mechanisms or repair factors [24,43]. The choice of
pathways to repair a DNA lesion is highly dependent on the
cell cycle phase and/or the physiological status of a cell
[25,57,58]. Our knowledge of DNA repair in cell cycle stems
from studies on the cycling somatic cells. Intriguingly, adults
HSCs reside in quiescent status (G0) [14]. Two repair scenarios
have been proposed to repair ionizing radiation (IR)-generated
DSBs in HSCs in G0 phase [59,60]. Passegue´ and her
colleagues found that quiescent HSCs use the same repair
program as in G1 phase of somatic cells, i.e., non-homologous
end joining (NHEJ) pathway to repair the IR-generated
DNA lesions [60]. In this scenario, upon DSB induction, pro-
tein complex comprising MRE11/RAD50/NBS1 is recruited to
the DSB sites and activates ATM kinase, which phosphory-
lates MDC1/H2AX/53BP1/SMC1/KAP1 to alter the chro-
matin status around the DSBs and CHK2/p53 to initiate the
cell cycle checkpoints and/or cell death signaling pathways
[24,61–63]. In addition, MRE11 nuclease resects the DNA
strand at DSBs to generate micro-homology to facilitate the
repair process [62,64,65]. This repair pathway is considered
as a low fidelity repair choice, since abnormal chromosome
fusions, loss of genetic material around the breakage sites,
and accumulation of genetic mutations could happen follow-
ing the repair [63]. Indeed, Passegue´ and her colleagues found
that 53BP1 foci (a marker of NHEJ) rather than RAD51 (a
marker of homologous recombination, HR) were prominently
evident in IR-treated quiescent HSCs [60]. Consequently, chro-
mosome analysis with spectral karyotyping (SKY) on the
hematopoietic progenitors derived from IR-irradiated HSCs
reveals a great increase in genome instabilities, including chro-
mosome fusions [60]. However, this repair pathway could not
effectively explain the accumulation of DNA break marker
c-H2AX in naturally-aged HSCs, because ligation of DNA
breaks by NHEJ quenches the DDR signaling and thereby
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quiescence is a cellular status when HSC loses its stringent
control of repair machineries [42,48]. Beerman et al. conducted
the in vitro short-term culture of isolated quiescent HSCs [48].
After 24 h, a significant reduction in c-H2AX-marked DSBs
was noticed when the HSCs enter the cell cycle [48], suggesting
that proliferating HSCs repair DSB better. G0 HSCs appar-
ently express low levels of DDR genes as compared to prolif-
erating HSCs (such as fetal liver HSCs) and progenitors [48].
In this way, DNA damage signaling may be attenuated in qui-
escent HSCs, which is consistent with the previous finding on
accumulation of DNA breaks in aged HSCs [8,42].
Once HSCs are mobilized and forced to enter cell cycle by
in vivo administration of cytokine granulocyte-colony stimulat-
ing factor (G-CSF) or cultured in vitro in the presence of the
stem cell factor (SCF), HSCs switch the repair mechanism
from NHEJ toward HR [60]. In S/G2/M HSCs, MRN com-
plex recruits ATM and resects the DSBs to generate the single
strand overhangs, which can activate ATR/CHK1 kinase
[63,66]. RAD51 is then loaded onto the exposed single strands
and forms DNA/protein filaments to initiate strand invasion
into their homologous chromosomes [67]. As compared with
NHEJ in G0/G1 cell cycle, HR is more stringent in keeping
the genomic integrity. However, although HSCs can faithfully
repair the DNA breaks when cycling [46,48,51], entry into cell
cycle could be detrimental to the quality of HSCs because
serial transplantation experiments in mice demonstrate that
HSCs have limited replicative lifespan and multiple rounds
of stress-induced HSC cycling can compromise self-renewal
and differentiation capacity, leading to exhaustion of the
HSC pool [12,46].
p53-p21/PUMA pathway in HSC cell fate
determination
DNA damages exhaust HSCs in terms of self-renewal and
differentiation by reducing the HSC pool (quantity) and com-
promising HSC stemness (quality) [26,35,45]. Upon DNA
damage, cells engage a serial of downstream cellular events
including cell cycle arrest, apoptosis, and transcriptional
reprogramming [43]. Faithful DNA repair preserves the
HSC genome integrity and sustains HSC stem cell identity
in proper self-renewal and differentiation. However, depend-
ing on the repair efficiency for certain DNA lesions, HSCs
undertake different fates toward permanent cell cycle arrest
(senescence), cell death (HSC elimination) [68,69], and even
differentiation [70–73]. As the HSC fate determinant, the
p53 pathway has been well studied in vivo [74,75]. The p53
pathway is transiently activated after a single dose of IR or
can be constantly activated in HSCs by persistent DNA dam-
ages, such as critically shortened telomeres [60,69,76]. Down-
stream of p53 signaling, p53 trans-activates p21 to promote
the cell survival by initiating cell cycle arrest for DNA repair
or cellular senescence, while induced expression of the p53
upregulated modulator of apoptosis (PUMA) by p53 is
responsible for cellular clearance (Figure 2) [13,68]. Inhibition
of either branch of p53-p21 or p53-PUMA benefits HSC self-
renewal and maintenance in several cases of HSC ageing mice
models [74,77–79]. Complete p53 loss renders cytoprotective
effects on IR-damaged HSCs [80] and promotes symmetric
division of HSCs to expand the HSC pool [74,81,82].However, these p53-null HSCs show defective differentiation
and are tumor-prone, indicating that p53 null compromises
the HSC quality [74,78]. In this regard, the balance of p21
and PUMA downstream of p53 signaling is essential for the
maintenance of HSCs and hematopoietic system [75,83].
Compared to hematopoietic progenitors, murine HSCs are
resistant to acute DNA damage induction and prone to sur-
vival [60]. This is likely due to a high expression level of the
pro-survival genes in murine HSCs [60]. In response to acute
DNA damage, HSCs tend to be arrested and reside in the
senescent status, suggesting that p53-p21 branch is activated
in HSCs preferably to limit HSC self-renewal [77,84]. Loss of
p21 in the mouse model with persistent DNA damage (the
3rd generation of Terc/ mice; G3 Terc/) with critically-
shortened telomeres could partially rescue ageing phenotypes
by improving the repopulation capacity and self-renewal of
HSCs [77]. Furthermore, activated p53-PUMA branch is
responsible for the HSC death upon lethal dose of c-
irradiation (10 Gy), since loss of PUMA protects the HSCs
and extends the lifespan of irradiated mice [85]. The constitu-
tive activation of p53 signaling in mice lines expressing p53
phosphorylation mutations (T21D and S23D), a C-terminal
truncated p53 allele, or other gene mutations confers
premature ageing of hematopoietic systems [13,86,87]. Genetic
ablation of Puma restores the viability of HSCs, indicating
p53-PUMA limiting the HSC pool size [85,86]. These data
point to a promising therapeutic strategy to protect HSCs
and prolong healthy lifespan with p21 or PUMA inhibitors.
However, it is of note that p21-null HSCs exhibit self-
renewal defects in serial transplantation assay, while
Puma-null HSCs are superior to their wild type controls
[86,88]. These findings indicate that p53-p21 and p53-PUMA
have differential roles in mediating HSC fates and ageing
due to different extents of DNA lesions (Figure 2).
Persistent DNA damage creates a pro-ageing
environment for HSCs
Intrinsic defects in repairing DNA damages and their contri-
butions to compromised HSC self-renewal and ageing
process have been extensively studied in recent years. How-
ever, ageing environments, such as mis-regulated cytokine
factor secretion and altered stem cells niches, can all affect
HSC maintenance (Figure 1) [4,76,89,90]. An interesting
example of the environmental impact on the HSC self-
renewal and differentiation comes from the parabiosis assay
by surgical connection between young and aged mice with
the circulatory blood system [91,92]. In this assay, young
and aged HSCs are unanimously exposed to a common sys-
tematic environment, such as serum factors and osteoblast
niches. Multi-organ analysis shows that the interconnection
of young and aged mice significantly improves tissue home-
ostasis including HSCs and hematopoietic system of the
aged mice. These data strongly indicate that a young system-
atic environment can rejuvenate the aged HSCs [91,92].
Although the search for the key factors in the systematic
environment that contribute to the ageing and rejuvenation
of stem cells is still ongoing, these findings conceptually
prove that the HSCs, in addition to the intrinsic regulation,
could be functionally modulated by the environmental cues.
On the other hand, parabiosis assay highlights a novel
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Figure 2 p53 signaling in HSC fate determination toward ageing
Hematopoietic stem cell fates are determined intrinsically with molecular events insides a HSC and extrinsically by its residing
environments, including HSC niche cells and circulating serum factors. p53 signaling plays important roles in HSC fate determination
upon DNA damage. After acute DNA damage induction, cell cycle arrest/senescence and cell death pathways medicated by p53-p21 and
p53-PUMA determine the HSC pool dynamics. Transcriptional regulation by stabilized p53 exerts additional impact on the HSC
transcriptome and leads to HSC differentiation, etc. Furthermore, senescent or heavily-damaged cells secrete pro-inflammatory cytokines
(SASP cytokines) to drive HSCs into cycling, which consequently triggers HSC exhaustion. SASP is proposed to be dependent on
p38MAPK-NF-jB signaling. In this scenario, p53 signaling plays beneficial roles in inhibiting the SASP by suppressing the p38MAPK
activation and subsequent NF-jB transcriptional activation. HSC, hematopoietic stem cell; SASP, senescence-associated secretory
phenotype; G-CSF, granulocyte-colony stimulating factor.
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reversed by rejuvenating serum factors [69,91,92].
Does DNA damage generate a systematic change and pro-
mote the HSC ageing? The analysis of HSCs from G3 Terc/
mice unveils some hints on this question. The critically-
shortened telomeres in G3 Terc/ mice can be recognized as
persistent DNA breaks, which constantly activate the p53-
p21/PUMA pathway in tissue-specific stem cells and their
somatic progenies [77,89,93]. Ju et al. analyzed the interplay
between HSCs and their niches, i.e., mesenchymal stem cell
(MSC)-derived bone marrow stromal cells. In G3 Terc/
mice, the functionality of both MSCs and bone marrow stro-
mal cells is compromised. In addition, the high level of
G-CSF cytokine in the G3 Terc/ mice serum significantly
reduces the engraftment of HSCs in bone marrow niches
[76]. G-CSF inhibition leads to the improved engraftment
and functionality of HSCs. These findings suggest that a cellu-
lar response from those ‘‘damaged” cells with persistent DNA
lesions caused by telomere shortening could alter the local
environment (such as HSC niches) or systematic environment
(i.e., cytokines or chemokines in serum) and confer a deleteri-
ous effect on self-renewal and maintenance of HSCs [69,76,89].
How persistent DNA damage signaling can change the sys-
tematic environment? One possibility could be the senescence-
associated secretory phenotype (SASP) [94,95]. Campisi and
colleagues found that senescent cells, although permanentlyarrested in cell cycle, is metabolically active in producing
inflammatory factors (SASP cytokines), such as IL-6, IL-10,
INF c, and G-CSF [94]. Furthermore, not only senescent cells,
but also cells with persistent DNA damages, exhibit SASP and
secrete pro-inflammatory cytokines to change systematic envi-
ronment in the animal tissues [96]. Activated NF-jB signaling
has been implicated in SASP, since inhibition of NF-jB signal-
ing by knocking down of p65 greatly alleviates the expression
of SASP cytokines [97–99]. Furthermore, activation of
p38MAPK kinase activity by various stimuli promotes SASP
induction. p38MAPK sits upstream of NF-jB signaling and
regulates the NF-jB activity. Interestingly, although p53 is
not required for initiating SASP, p53 restrains SASP once
the cellular senescence is established, since p53-null cells show
enhanced expression of SASP cytokines [99]. The inhibitory
effects of SASP by p53 could be attributed to the fact that
p53 restrains p38MAPK activity via its DDR-independent
activity. In this sense, p53 DDR-independent signaling may
provide protective roles in maintaining HSC homeostasis by
inhibiting SASP in the systematic environment of hematopoi-
etic system (Figure 2).
The secreted inflammatory factors from these cells with
persistent DNA damages, may be detrimental to the HSC
self-renewal and maintenance. For example, G-CSF mobilizes
the HSCs out of bone marrow niches and impairs their engraft-
ment [76,100]. IL6, INFa, and INF c have been implicated in
152 Genomics Proteomics Bioinformatics 14 (2016) 147–154promoting the cell cycle entry of HSCs, resulting in HSC
exhaustion toward ageing [90,101]. Tissues in aged animals
are enriched in senescent somatic cells that contain persistent
DNA damages. Furthermore, ageing process positively
correlates with increased inflammatory responses [102], which
may further ameliorate the HSC maintenance and promote
ageing [103]. Recent studies indicate that interfering with SASP
by blocking the cytokine production pathway or eliminating
cytokine-producing cells in tissues greatly improves the tissue
function and animal lifespan. Clearance of p16Ink4a-positive
senescent cells in progeroid BubR1 mutant mice could substan-
tially delay the onset of ageing phenotypes and even rejuvenate
the ageing tissues when such cellular clearance was applied in
late-life of BubR1 mutants [104]. Furthermore, Chang et al.
employed ABT263, a specific chemical inhibitor for Bcl-2 and
Bcl-xL, to induce the apoptosis of senescent HSCs. They found
that ABT263 treatment restores the functionality of HSCs in
the sub-lethally irradiated wild type mice and naturally-aged
mice, thus greatly improving the healthy lifespan of mice
[105]. The data further confirm the assumption that senescent
cells with persistent DNA damage can establish a systematic
environment driving HSC ageing.Conclusions and perspectives
Integrities of HSC pool and HSC quality are considered as the
key factors contributing to the organismal ageing in mammals
[4,29]. DDR plays essential roles in the maintenance of these
two HSC features [8,44,45,52,68]. Deficiency in DNA repair
results in the accumulation of unrepaired DNA breaks in aged
HSCs, while persistent DNA breaks in hematopoietic cells and
HSC niches create a pro-inflammatory environment to pro-
mote HSC entry into cell cycle and proliferation, which conse-
quently exhausts HSCs [69]. It would be very tricky to
experimentally modify those ageing HSCs with genetic
approaches in order to achieve the better DNA repair and
functional improvement. Instead, using bio-active cytokines
to interfere with the systematic ageing environment or using
small chemical molecules to specially remove the ‘‘aged” HSCs
would be the reliable and practical strategies to rejuvenate
the ageing HSCs and prolong the healthy lifespan of
mammals [105,106].Competing interests
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